FoxO3a Transcriptional Regulation of Bim Controls Apoptosis in Paclitaxel-treated Breast Cancer Cell Lines
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Paclitaxel is used to treat breast cancers, but the mechanisms by which it induces apoptosis are poorly understood. Consequently, we have studied the role of the FoxO transcription factors in determining cellular response to paclitaxel. Western blotting revealed that in a panel of nine breast cancer cell lines expression of FoxO1a and FoxO3a correlated with the expression of the pro-apoptotic FoxO target Bim, which was associated with paclitaxel-induced apoptosis. In MCF-7 cells, which were paclitaxel-sensitive, the already high basal levels of FoxO3a and Bim protein increased dramatically after drug treatment, as did Bim mRNA, which correlated with apoptosis induction. This was not observed in MDA-231 cells, which expressed low levels of FoxOs and Bim. Gene reporter experiments demonstrated that in MCF-7 cells maximal induction of Bim promoter was dependent on a FoxO binding site, suggesting that FoxO3a is responsible for the transcriptional up-regulation of Bim. Gene silencing experiments showed that small interference RNA (siRNA) specific for FoxO3a reduced the levels of FoxO3a and Bim protein as well as inhibited apoptosis in paclitaxel-treated MCF-7 cells. Furthermore, siRNA specific for Bim reduced the levels of Bim protein and inhibited apoptosis in paclitaxel-treated MCF-7 cells. This is the first demonstration that up-regulation of FoxO3a by paclitaxel can result in increased levels of Bim mRNA and protein, which can be a direct cause of apoptosis in breast cancer cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The suppression of the AKT pathway activates downstream FoxO3a, resulting in the restoration of Bim transcriptional induction by FoxO3a [45, 46].”
Citations
Cites
The phosphoinositide 3-kinase pathway
Cantley, L. C. (2002) · Science · doi:10.1126/science.296.5573.1655 · Cited by 5,621
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress
Kops, G. J. P. L., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W. A., Coffer, P. J., Huang, T.-T., Bos, J. L., Medema, R. H., & Burgering, B. M. T. (2002) · Nature · doi:10.1038/nature01036 · Cited by 1,580
Self-citationBouillet, P., Metcalf, D., Huang, D. C. S., Tarlinton, D. M., Kay, T. W. H., Köntgen, F., Adams, J. M., & Strasser, A. (1999) · Science · doi:10.1126/science.286.5445.1735 · Cited by 1,504
AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1
Medema, R. H., Kops, G. J. P. L., Bos, J. L., & Burgering, B. M. T. (2000) · Nature · doi:10.1038/35008115 · Cited by 1,438
Self-citationBiggs, W. H., Meisenhelder, J., Hunter, T., Cavenee, W. K., & Arden, K. C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7421 · Cited by 1,116
JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis
Lei, K., & Davis, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438011100 · Cited by 1,068
Puthalakath, H., Huang, D. C. S., O’Reilly, L. A., King, S. M., & Strasser, A. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80456-6 · Cited by 1,054
Dijkers, P. F., Medema†, R. H., Lammers, J.-W. J., Koenderman, L., & Coffer, P. J. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00728-4 · Cited by 976
Self-citationPhosphoinositide 3-kinases: A conserved family of signal transducers
Vanhaesebroeck, B., Leevers, S. J., Panayotou, G., & Waterfield, M. D. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01061-x · Cited by 954
Research works printed but not linked: 3
- Page, 2000, Int. J. Oncol., 17, 23
- Tanabe, 2003, Int. J. Oncol., 22, 875
- Clark, 2002, Mol. Cancer Ther., 1, 707
Cited by
Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy
Fulda, S., & Debatin, K.-M. (2006) · Oncogene · doi:10.1038/sj.onc.1209608 · Cited by 2,312
“The BH3-only protein Bim, which is associated with the cytoskeleton by binding to microtubules, is set free and activates the intrinsic pathway following treatment with taxol, which acts on microtubule assembly (Sunters et al., 2003).”
BackgroundAkt, FoxO and regulation of apoptosis
Zhang, X., Tang, N., Hadden, T. J., & Rishi, A. K. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.03.010 · Cited by 1,103
The emerging roles of forkhead box (Fox) proteins in cancer
Myatt, S. S., & Lam, E. W. F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2223 · Cited by 1,070
Self-citationThe ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation
van der HEIDE, L. P., HOEKMAN, M. F. M., & SMIDT, M. P. (2004) · Biochemical Journal · doi:10.1042/bj20040167 · Cited by 691
FOXOs, cancer and regulation of apoptosis
Fu, Z., & Tindall, D. J. (2008) · Oncogene · doi:10.1038/onc.2008.24 · Cited by 584
Fernald, K., & Kurokawa, M. (2013) · Trends in Cell Biology · doi:10.1016/j.tcb.2013.07.006 · Cited by 579
Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
Guttilla, I. K., & White, B. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.031427 · Cited by 560
Paraiso, K. H. T., Xiang, Y., Rebecca, V. W., Abel, E. V., Chen, Y. A., Munko, A. C., Wood, E., Fedorenko, I. V., Sondak, V. K., Anderson, A. R. A., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2954 · Cited by 551
The BCL-2 protein family, BH3-mimetics and cancer therapy
Delbridge, A. R. D., & Strasser, A. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.50 · Cited by 531
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
Vogler, M., Braun, Y., Smith, V. M., Westhoff, M.-A., Pereira, R. S., Pieper, N. M., Anders, M., Callens, M., Vervliet, T., Abbas, M., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02176-0 · Cited by 462
BH3-only proteins in apoptosis and beyond: an overview
Lomonosova, E., & Chinnadurai, G. (2008) · Oncogene · doi:10.1038/onc.2009.39 · Cited by 458
FOXO Transcription Factors: Their Clinical Significance and Regulation
Wang, Y., Zhou, Y., & Graves, D. T. (2014) · BioMed Research International · doi:10.1155/2014/925350 · Cited by 419
FOXM1: From cancer initiation to progression and treatment
Koo, C.-Y., Muir, K. W., & Lam, E. W.-F. (2012) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.09.004 · Cited by 406
Self-citationPastorino, J. G., Hoek, J. B., & Shulga, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1925 · Cited by 398
Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
Mosca, L., Ilari, A., Fazi, F., Assaraf, Y. G., & Colotti, G. (2021) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100742 · Cited by 385
Kong, W., He, L., Coppola, M., Guo, J., Esposito, N. N., Coppola, D., & Cheng, J. Q. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101055 · Cited by 377
RetractedFOXO3: A Major Gene for Human Longevity - A Mini-Review
Morris, B. J., Willcox, D. C., Donlon, T. A., & Willcox, B. J. (2015) · Gerontology · doi:10.1159/000375235 · Cited by 353
The Role of Growth Factors and Cytokines during Implantation: Endocrine and Paracrine Interactions
Guzeloglu-Kayisli, O., Kayisli, U., & Taylor, H. (2009) · Seminars in Reproductive Medicine · doi:10.1055/s-0028-1108011 · Cited by 314
Wu, W., Chaudhuri, S., Brickley, D. R., Pang, D., Karrison, T., & Conzen, S. D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2546 · Cited by 314
Hercus, T. R., Thomas, D., Guthridge, M. A., Ekert, P. G., King-Scott, J., Parker, M. W., & Lopez, A. F. (2009) · Blood · doi:10.1182/blood-2008-12-164004 · Cited by 307
Essafi, A., Fernández de Mattos, S., Hassen, Y. A. M., Soeiro, I., Mufti, G. J., Thomas, N. S. B., Medema, R. H., & Lam, E. W.-F. (2005) · Oncogene · doi:10.1038/sj.onc.1208421 · Cited by 293
Self-citationTGF-β upregulates miR-181a expression to promote breast cancer metastasis
Taylor, M. A., Sossey-Alaoui, K., Thompson, C. L., Danielpour, D., & Schiemann, W. P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64946 · Cited by 288
FOXO transcription factors in cancer development and therapy
Coomans de Brachène, A., & Demoulin, J.-B. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2112-y · Cited by 284
Key roles of BIM-driven apoptosis in epithelial tumors and rational chemotherapy
Tan, T.-T., Degenhardt, K., Nelson, D. A., Beaudoin, B., Nieves-Neira, W., Bouillet, P., Villunger, A., Adams, J. M., & White, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.008 · Cited by 284
FOXO transcription factor family in cancer and metastasis
Jiramongkol, Y., & Lam, E. W.-F. (2020) · Cancer and Metastasis Reviews · doi:10.1007/s10555-020-09883-w · Cited by 281
Self-citationOverview of Major Classes of Plant-Derived Anticancer Drugs
Amin, A., Gali‐Muhtasib, H. U., Ocker, M., & Schneider‐Stock, R. (2009) · International Journal of Biomedical Science · doi:10.59566/ijbs.2009.5001 · Cited by 267
Principe, D. R., Underwood, P. W., Korc, M., Trevino, J. G., Munshi, H. G., & Rana, A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.688377 · Cited by 250
Sunters, A., Madureira, P. A., Pomeranz, K. M., Aubert, M., Brosens, J. J., Cook, S. J., Burgering, B. M. T., Coombes, R. C., & Lam, E. W.-F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1997 · Cited by 249
Self-citationThe Extending Network of FOXO Transcriptional Target Genes
van der Vos, K. E., & Coffer, P. J. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3419 · Cited by 243
Self-citationEvidence That Ser87 of BimEL Is Phosphorylated by Akt and Regulates BimEL Apoptotic Function
Qi, X.-J., Wildey, G. M., & Howe, P. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505546200 · Cited by 234
Khongkow, P., Gomes, A. R., Gong, C., Man, E. P. S., Tsang, J. W.-H., Zhao, F., Monteiro, L. J., Coombes, R. C., Medema, R. H., Khoo, U. S., et al. (2016) · Oncogene · doi:10.1038/onc.2015.152 · Cited by 233
Self-citation4-1BB costimulation promotes CAR T cell survival through noncanonical NF-κB signaling
Philipson, B. I., O’Connor, R. S., May, M. J., June, C. H., Albelda, S. M., & Milone, M. C. (2020) · Science Signaling · doi:10.1126/scisignal.aay8248 · Cited by 232
A New Fork for Clinical Application: Targeting Forkhead Transcription Factors in Cancer
Yang, J.-Y., & Hung, M.-C. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0124 · Cited by 228
Takano, M., Lu, Z., Goto, T., Fusi, L., Higham, J., Francis, J., Withey, A., Hardt, J., Cloke, B., Stavropoulou, A. V., et al. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0058 · Cited by 224
Self-citationThe FOXO3-FOXM1 axis: A key cancer drug target and a modulator of cancer drug resistance
Yao, S., Fan, L. Y.-N., & Lam, E. W.-F. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.11.018 · Cited by 223
Self-citationTai, X., Erman, B., Alag, A., Mu, J., Kimura, M., Katz, G., Guinter, T., McCaughtry, T., Etzensperger, R., Feigenbaum, L., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.022 · Cited by 218
Regulation of Bim in Health and Disease
Sionov, R. V., Vlahopoulos, S. A., & Granot, Z. (2015) · Oncotarget · doi:10.18632/oncotarget.5492 · Cited by 216
FOXO transcription factors: key regulators of cell fate
Lam, E. W.-F., Francis, R. E., & Petkovic, M. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340722 · Cited by 215
Self-citationRiou, C., Yassine-Diab, B., Van grevenynghe, J., Somogyi, R., Greller, L. D., Gagnon, D., Gimmig, S., Wilkinson, P., Shi, Y., Cameron, M. J., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061681 · Cited by 209
Martelli, A. M., Evangelisti, C., Chappell, W., Abrams, S. L., Bäsecke, J., Stivala, F., Donia, M., Fagone, P., Nicoletti, F., Libra, M., et al. (2011) · Leukemia · doi:10.1038/leu.2011.46 · Cited by 204
Effects of high glucose on mesenchymal stem cell proliferation and differentiation
Li, Y.-M., Schilling, T., Benisch, P., Zeck, S., Meissner-Weigl, J., Schneider, D., Limbert, C., Seufert, J., Kassem, M., Schütze, N., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.08.161 · Cited by 198
Taxol Induces Caspase-10-dependent Apoptosis
Park, S.-J., Wu, C.-H., Gordon, J. D., Zhong, X., Emami, A., & Safa, A. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406543200 · Cited by 198
Inhibition of the Androgen Receptor as a Novel Mechanism of Taxol Chemotherapy in Prostate Cancer
Gan, L., Chen, S., Wang, Y., Watahiki, A., Bohrer, L., Sun, Z., Wang, Y., & Huang, H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1504 · Cited by 197
BH3-only proteins in apoptosis at a glance
Happo, L., Strasser, A., & Cory, S. (2012) · Journal of Cell Science · doi:10.1242/jcs.090514 · Cited by 193
Transcriptional Regulation of Bim by FoxO3A Mediates Hepatocyte Lipoapoptosis
Barreyro, F. J., Kobayashi, S., Bronk, S. F., Werneburg, N. W., Malhi, H., & Gores, G. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704391200 · Cited by 190
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
Shukla, S., Bhaskaran, N., Babcook, M. A., Fu, P., MacLennan, G. T., & Gupta, S. (2014) · Carcinogenesis · doi:10.1093/carcin/bgt316 · Cited by 188
Lin, H., Dai, T., Xiong, H., Zhao, X., Chen, X., Yu, C., Li, J., Wang, X., & Song, L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015797 · Cited by 185
Bali, P., Pranpat, M., Swaby, R., Fiskus, W., Yamaguchi, H., Balasis, M., Rocha, K., Wang, H.-G., Richon, V., & Bhalla, K. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0344 · Cited by 184
Nguyen, L. T., Lee, Y.-H., Sharma, A. R., Park, J.-B., Jagga, S., Sharma, G., Lee, S.-S., & Nam, J.-S. (2017) · The Korean Journal of Physiology & Pharmacology · doi:10.4196/kjpp.2017.21.2.205 · Cited by 182
Targeting anoikis resistance in prostate cancer metastasis
Sakamoto, S., & Kyprianou, N. (2010) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2010.02.001 · Cited by 180
Kajihara, T., Jones, M., Fusi, L., Takano, M., Feroze-Zaidi, F., Pirianov, G., Mehmet, H., Ishihara, O., Higham, J. M., Lam, E. W.-F., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0118 · Cited by 180
Self-citationPaschos, K., Smith, P., Anderton, E., Middeldorp, J. M., White, R. E., & Allday, M. J. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000492 · Cited by 177
Kato, M., Yuan, H., Xu, Z.-G., Lanting, L., Li, S.-L., Wang, M., Hu, M. C.-T., Reddy, M. A., & Natarajan, R. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006070754 · Cited by 175
McCubrey, J. A., Steelman, L. S., Kempf, C. R., Chappell, W. H., Abrams, S. L., Stivala, F., Malaponte, G., Nicoletti, F., Libra, M., Bäsecke, J., et al. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22647 · Cited by 171
The HSP90 Inhibitor XL888 Overcomes BRAF Inhibitor Resistance Mediated through Diverse Mechanisms
Paraiso, K. H. T., Haarberg, H. E., Wood, E., Rebecca, V. W., Chen, Y. A., Xiang, Y., Ribas, A., Lo, R. S., Weber, J. S., Sondak, V. K., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2612 · Cited by 169
Many forks in the path: cycling with FoxO
Ho, K. K., Myatt, S. S., & Lam, E. W.-F. (2008) · Oncogene · doi:10.1038/onc.2008.23 · Cited by 169
Self-citationSIRT6 modulates paclitaxel and epirubicin resistance and survival in breast cancer
Khongkow, M., Olmos, Y., Gong, C., Gomes, A. R., Monteiro, L. J., Yagüe, E., Cavaco, T. B., Khongkow, P., Man, E. P. S., Laohasinnarong, S., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt098 · Cited by 168
Self-citationNRAS mutant melanoma: biological behavior and future strategies for therapeutic management
Fedorenko, I. V., Gibney, G. T., & Smalley, K. S. M. (2013) · Oncogene · doi:10.1038/onc.2012.453 · Cited by 167
Rahmani, M., Aust, M. M., Attkisson, E., Williams, D. C., Ferreira‐Gonzalez, A., & Grant, S. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-1365 · Cited by 165
Bim-targeted cancer therapy: A link between drug action and underlying molecular changes
Akiyama, T., Dass, C. R., & Choong, P. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0685 · Cited by 165
Flavones inhibit breast cancer proliferation through the Akt/FOXO3a signaling pathway
Lin, C.-H., Chang, C.-Y., Lee, K., Lin, H.-J., Chen, T.-H., & Wan, L. (2015) · BMC Cancer · doi:10.1186/s12885-015-1965-7 · Cited by 164
FoxO3a and disease progression
Nho, R. S. (2014) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v5.i3.346 · Cited by 164
Weisová, P., Concannon, C. G., Devocelle, M., Prehn, J. H. M., & Ward, M. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.0354-09.2009 · Cited by 161
Liu, H., Yin, J., Wang, H., Jiang, G., Deng, M., Zhang, G., Bu, X., Cai, S., Du, J., & He, Z. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.01.001 · Cited by 161
Yano, T., Ito, K., Fukamachi, H., Chi, X.-Z., Wee, H.-J., Inoue, K.-I., Ida, H., Bouillet, P., Strasser, A., Bae, S.-C., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01926-05 · Cited by 161
The role of insulin and IGF-1 signaling in longevity
Katic, M., & Kahn, C. R. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4297-y · Cited by 159
BCL-2 family regulation by the 20S proteasome inhibitor bortezomib
Fennell, D. A., Chacko, A., & Mutti, L. (2007) · Oncogene · doi:10.1038/sj.onc.1210744 · Cited by 157
Karadedou, C. T., Gomes, A. R., Chen, J., Petkovic, M., Ho, K.-K., Zwolinska, A. K., Feltes, A., Wong, S. Y., Chan, K. Y. K., Cheung, Y.-N., et al. (2012) · Oncogene · doi:10.1038/onc.2011.368 · Cited by 154
Self-citationRelling, D. P., Esberg, L. B., Fang, C. X., Johnson, W. T., Murphy, E. J., Carlson, E. C., Saari, J. T., & Ren, J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000203846.34314.94 · Cited by 151
Hui, R. C.-Y., Gomes, A. R., Constantinidou, D., Costa, J. R., Karadedou, C. T., Fernandez de Mattos, S., Wymann, M. P., Brosens, J. J., Schulze, A., & Lam, E. W.-F. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01265-07 · Cited by 151
Self-citationConcannon, C. G., Tuffy, L. P., Weisová, P., Bonner, H. P., Dávila, D., Bonner, C., Devocelle, M. C., Strasser, A., Ward, M. W., & Prehn, J. H. M. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200909166 · Cited by 150
A Small-Molecule Inhibitor for Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN)
Rosivatz, E., Matthews, J. G., McDonald, N. Q., Mulet, X., Ho, K. K., Lossi, N., Schmid, A. C., Mirabelli, M., Pomeranz, K. M., Erneux, C., et al. (2006) · ACS Chemical Biology · doi:10.1021/cb600352f · Cited by 148
Self-citationBim and Bmf in tissue homeostasis and malignant disease
Piñon, J. D., Labi, V, Egle, A., & Villunger, A. (2008) · Oncogene · doi:10.1038/onc.2009.42 · Cited by 148
LI, R., Moudgil, T. L., Ross, H. J., & Hu, H. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401554 · Cited by 147
Inta, I. M., Paxian, S. A., Maegele, I., Zhang, W., Pizzi, M., Spano, P., Sarnico, I., Muhammad, S., Herrmann, O., Inta, D., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3670-06.2006 · Cited by 147
Death or survival – progesterone-dependent cell fate decisions in the human endometrial stroma
Brosens, J. J., & Gellersen, B. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02060 · Cited by 146
Self-citationFoxO transcription factors in cancer metabolism
Yadav, R. K., Chauhan, A. S., Zhuang, L., & Gan, B. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.01.004 · Cited by 146
RUNX3 Cooperates with FoxO3a to Induce Apoptosis in Gastric Cancer Cells
Yamamura, Y., Lee, W. L., Inoue, K.-I., Ida, H., & Ito, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512151200 · Cited by 144
Ho, K.-K., McGuire, V. A., Koo, C.-Y., Muir, K. W., de Olano, N., Maifoshie, E., Kelly, D. J., McGovern, U. B., Monteiro, L. J., Gomes, A. R., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.284224 · Cited by 142
Self-citationKutuk, O., & Letai, A. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1418 · Cited by 141
Inhibition of AKT promotes FOXO3a-dependent apoptosis in prostate cancer
Das, T. P., Suman, S., Alatassi, H., Ankem, M. K., & Damodaran, C. (2016) · Cell Death and Disease · doi:10.1038/cddis.2015.403 · Cited by 138
Labied, S., Kajihara, T., Madureira, P. A., Fusi, L., Jones, M. C., Higham, J. M., Varshochi, R., Francis, J. M., Zoumpoulidou, G., Essafi, A., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0275 · Cited by 134
Self-citationSamuel, S. M., Thirunavukkarasu, M., Penumathsa, S. V., Paul, D., & Maulik, N. (2008) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf802050h · Cited by 133
Lin, C., Wu, Z., Lin, X., Yu, C., Shi, T., Zeng, Y., Wang, X., Li, J., & Song, L. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3068 · Cited by 131
Yamaguchi, H., Chen, J., Bhalla, K., & Wang, H.-G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401530200 · Cited by 129
Zheng, X., Zhai, B., Koivunen, P., Shin, S. J., Lu, G., Liu, J., Geisen, C., Chakraborty, A. A., Moslehi, J. J., Smalley, D. M., et al. (2014) · Genes & Development · doi:10.1101/gad.242131.114 · Cited by 128
Xie, G., Zhu, X., Li, Q., Gu, M., He, Z., Wu, J., Li, J., Lin, Y., Li, M., She, Z., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00577.x · Cited by 127
The role of FOXO1 in the decidual transformation of the endometrium and early pregnancy
Kajihara, T., Brosens, J. J., & Ishihara, O. (2013) · Medical Molecular Morphology · doi:10.1007/s00795-013-0018-z · Cited by 126
Self-citationMonsalve, M., & Olmos, Y. (2011) · Current Drug Targets · doi:10.2174/138945011796150307 · Cited by 124
Sharma, G., Kar, S., Palit, S., & Das, P. K. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22920 · Cited by 124
Abrams, M. T., Robertson, N. M., Yoon, K., & Wickstrom, E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m411767200 · Cited by 122
The FOXM1–ABCC5 axis contributes to paclitaxel resistance in nasopharyngeal carcinoma cells
Hou, Y., Zhu, Q., Li, Z., Peng, Y., Yu, X., Yuan, B., Liu, Y., Liu, Y., Yin, L., Peng, Y., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.53 · Cited by 120
Chen, J., Gomes, A., Monteiro, L. J., Wong, S. Y., Wu, L. H., Ng, T.-T., Karadedou, C. T., Millour, J., Ip, Y.-C., Cheung, Y.-N., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012293 · Cited by 118
Self-citationA specific role for phosphoinositide 3-kinase and AKT in osteoblasts?
McGonnell, I. M., Grigoriadis, A. E., Lam, E. W. ‐., Price, J. S., & Sunters, A. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00088 · Cited by 117
Self-citationMicrotubule-targeted agents: When mitochondria become essential to chemotherapy
Rovini, A. M. F., Savry, A., Braguer, D., & Carré, M. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.01.001 · Cited by 115
Wang, F., Marshall, C. B., Yamamoto, K., Li, G.-Y., Gasmi-Seabrook, G. M. C., Okada, H., Mak, T. W., & Ikura, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119073109 · Cited by 115
SUMOylation inhibits FOXM1 activity and delays mitotic transition
Myatt, S. S., Kongsema, M., Man, C. W.-Y., Kelly, D. J., Gomes, A., Khongkow, P., Karunarathna, U., Zona, S., Langer, J. K., Dunsby, C. W., et al. (2013) · Oncogene · doi:10.1038/onc.2013.546 · Cited by 115
Self-citationYang, Y., Zhao, Y., Liao, W., Yang, J., Wu, L., Zheng, Z., Yu, Y., Zhou, W., Li, L., Feng, J., et al. (2009) · Neoplasia · doi:10.1593/neo.81358 · Cited by 114
PARK, S.-H. G., LEE, J. G., Berek, J. S., & HU, M. Y. C.-T. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2579 · Cited by 114
Goto, T., Takano, M., Albergaria, A., Briese, J., Pomeranz, K. M., Cloke, B., Fusi, L., Feroze-Zaidi, F., Maywald, N., Sajin, M., et al. (2007) · Oncogene · doi:10.1038/sj.onc.1210626 · Cited by 114
Self-citation
Metadata
- Authors
- Sunters, A., Fernández de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C., & Lam, E. W.-F.
- Affiliations
- Cancer Research UK (GB)
- The Netherlands Cancer Institute (NL)
- Hammersmith Hospital (GB)
- University Medical Center Utrecht (NL)
- Corresponding author
- Lam, Eric W.-F.
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2003-12
- Volume
- 278
- Issue
- 50
- Pages
- 49795-49805
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1422650632
- Cited by
- 505
- References
- 52
- Citations by year
- 2026: 2 · 2025: 9 · 2024: 9 · 2023: 19 · 2022: 9 · 2021: 14 · 2020: 22 · 2019: 27 · 2018: 16 · 2017: 24 · 2016: 10 · 2015: 27 · 2014: 34 · 2013: 39 · 2012: 32
- FWCI
- 6.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6139 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion)
- RVC Research Online (Royal Veterinary College) (submittedVersion, cc-by)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- FOXO3, building information modeling, apoptosis, paclitaxel, breast cancer, FOXO transcription factors, transcriptional regulation, MCF-7 cells, MDA-MB-231 cells, drug resistance, siRNA knockdown
- MeSH terms
- Forkhead Box Protein O1, Bcl-2-Like Protein 11, Antineoplastic Agents, Phytogenic, Binding Sites, Breast Neoplasms, Carrier Proteins, Cell Line, DNA-Binding Proteins, Humans, Membrane Proteins, Mitosis, Promoter Regions, Genetic, Proto-Oncogene Proteins, RNA, Messenger, Time Factors, Transcription Factors, Transcription, Genetic, Transfection, Blotting, Western, Up-Regulation, Gene Expression Regulation, Neoplastic, G2 Phase, Apoptosis, Paclitaxel, Annexin A5, Genes, Reporter, Reverse Transcriptase Polymerase Chain Reaction, RNA, Small Interfering, Cell Line, Tumor, Apoptosis Regulatory Proteins, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.